Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline
NCT03585907 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2019-10-03
Summary
This study aims to assess if/how dietary interventions (i.e., the Modified Atkins Diet (MAD) and/or the Mediterranean-Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND)) might prevent, delay onset, alleviate symptoms, or otherwise alter the course of subjective cognitive decline (SCD) likely due to Alzheimer's disease (AD).
We hypothesize that participants will tolerate both diets well and that the MAD will result in more favorable changes in cognition and other functioning.
Conditions
- Alzheimer Disease
- Cognitive Impairment
Interventions
- DIETARY_SUPPLEMENT
-
MAD
A high fat, low carbohydrate diet
- DIETARY_SUPPLEMENT
-
MIND
A combination of the Mediterranean and DASH diets
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-02
- Primary Completion
- 2021-09-01
- Completion
- 2021-09-01
More Related Trials
-
Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects
NCT01702480 ·Status: COMPLETED ·Phase: PHASE1
-
Medication Repurposing to Stop Cognitive Decline in Dementia
NCT05817188 ·Status: COMPLETED
-
Feasibility and Efficacy of the Ketogenic Diet in Alzheimer's Disease
NCT03690193 ·Status: COMPLETED ·Phase: NA
-
Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults.
NCT03145987 ·Status: COMPLETED ·Phase: NA
-
Multicultural Healthy Diet to Reduce Cognitive Decline
NCT03240406 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of a Low Protein Diet in Patients With Cognitive Impairment
NCT05480358 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
NCT03514875 ·Status: WITHDRAWN ·Phase: NA
-
Non-pharmacological Intervention for Preclinical Alzheimer's Disease
NCT04279418 ·Status: COMPLETED ·Phase: NA
-
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936 ·Status: COMPLETED ·Phase: NA
-
An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population
NCT02249468 ·Status: TERMINATED
-
Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks
NCT05007730 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment
NCT02573740 ·Status: TERMINATED ·Phase: PHASE1
-
The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease
NCT00006187 ·Status: TERMINATED ·Phase: PHASE3
-
12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension
NCT02586909 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease
NCT03462121 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Cognitive Decline With Alternative Therapies
NCT00010920 ·Status: COMPLETED ·Phase: PHASE3
-
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
NCT03486938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
The Ketogenic Diet in the Treatment of Alzheimer's Disease
NCT06681948 ·Status: COMPLETED ·Phase: NA
-
Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants
NCT02769065 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluating Cognitive and Functional Impairment in Alzheimer's Dementia With a Ketogenic Diet.
NCT04396015 ·Status: COMPLETED ·Phase: NA
-
Alzheimer's Tau Platform: Master Protocol
NCT06957418 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment
NCT03482167 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Ketogenic Diet for Alzheimer's Disease
NCT04701957 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
NCT03316898 ·Status: WITHDRAWN ·Phase: PHASE1